SCHEMBL403651

SCHEMBL403651

c1ccc(-c2cc3ccccc3s2)nc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.60
KDM4E B2RXH2 8/20 0.59
NPC1 O15118 3/20 0.59
RAB9A P51151 3/20 0.59
MAPT P10636 2/20 0.59
GLA P06280 1/20 0.59
TP53 P04637 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
ALDH1A1 P00352 1/20 0.51
TSHR P16473 1/20 0.51
HSD17B10 Q99714 1/20 0.51
KDM1A O60341 1/20 0.51
CYP11B1 P15538 1/20 0.50
CYP11B2 P19099 1/20 0.50
APP P05067 2/20 0.47
CCR1 P32246 3/20 0.46
CCR5 P51681 3/20 0.46
CCR8 P51685 3/20 0.46
LMNA P02545 2/20 0.46
CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29415478 1.00 CYP19A1 (0.60) CYP19A1KDM4ENPC1RAB9AMAPT
SCHEMBL6230863 0.98 CYP19A1 (0.59) CYP19A1KDM4ENPC1RAB9AMAPT
SCHEMBL27657937 0.98 CYP19A1 (0.59) CYP19A1KDM4ENPC1RAB9AMAPT
SCHEMBL30103498 0.98 CYP19A1 (0.59) CYP19A1KDM4ENPC1RAB9AMAPT
SCHEMBL2517455 0.98 CYP19A1 (0.59) CYP19A1KDM4ENPC1RAB9AMAPT
SCHEMBL29675208 0.98 CYP19A1 (0.59) CYP19A1KDM4ENPC1RAB9AMAPT
SCHEMBL30109437 0.98 CYP19A1 (0.59) CYP19A1KDM4ENPC1RAB9AMAPT
SCHEMBL31103353 0.93 CYP19A1 (0.55) CYP19A1KDM4ENPC1RAB9AMAPT
Pyridine SCHEMBL29277407 0.93 CYP19A1 (0.55) CYP19A1KDM4ENPC1RAB9AMAPT
SCHEMBL13299935 0.87 KDM4E (0.61) CYP19A1KDM4ENPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026047173-A1 PROCESS FOR PREPARING SUSTAINABLE JET FUELS OR DIESEL FUELS; AND PRECURSORS THEREOF Terra Mater BV (BE) 2026-03-05 WO claimed
WO-2024126392-A1 VECTORIZED NHC IRIDIUM(III) COMPLEXES AND USE THEREOF IN PHOTODYNAMIC THERAPY AND/OR DIAGNOSTIC CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2024-06-20 WO claimed
EP-4385995-A1 VECTORIZED NHC IRIDIUM(III) COMPLEXES AND USE THEREOF IN PHOTODYNAMIC THERAPY AND/OR DIAGNOSTIC Centre National de la Recherche Scientifique (FR) 2024-06-19 EP claimed
WO-2024110575-A1 OLIGOMERISATION OF ALCOHOLS Terra Mater BV (BE) 2024-05-30 WO claimed
CN-112979713-A Compound, light-emitting layer guest material, organic electroluminescent device and display device 北京师范大学 2021-06-18 CN claimed
EP-2278637-B2 Complexes of form L2MX UNIV PRINCETON (US) 2021-06-09 EP claimed
EP-2499181-B1 POLYMER FOR OPTOELECTRONIC DEVICE BOE TECHNOLOGY GROUP CO LTD (CN) 2020-05-13 EP claimed
US-10629827-B2 Organometallic complexes as phosphorescent emitters in organic LEDs THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2020-04-21 US claimed
EP-1933395-B2 Complexes of form L2IrX UNIV PRINCETON (US) 2019-08-07 EP claimed
EP-3379591-A1 COMPLEXES OF FORM L2MX The Trustees of Princeton University (US) 2018-09-26 EP claimed
US-20040247934-A1 Light emitting material and organic light-emitting device SAMSUNG ELECTRONICS CO., LTD (KR) 2004-12-09 US claimed
CN-1554128-A Light emitting material and organic light-emitting device �Ѻ͵繤��ʽ���� 2004-12-08 CN claimed
EP-1407501-A2 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE Showa Denko K.K. (JP) 2004-04-14 EP claimed
CN-1413426-A Complexes in the form of phosphorescent dopants L2MX as organic light-emitting devices UNIV PRINCETON (US) 2003-04-23 CN claimed
EP-1252803-A4 COMPLEXES OF FORM L 2?MX AS PHOSPHORESCENT DOPANTS FOR ORGANIC LEDS UNIV PRINCETON (US) 2003-04-16 EP claimed
US-20030017361-A1 Organometallic complexes as phosphorescent emitters in organic LEDs THOMPSON MARK E (US) 2003-01-23 US claimed
WO-2003001616-A2 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE SHOWA DENKO K.K. (JP) 2003-01-03 WO claimed
EP-1252803-A1 COMPLEXES OF FORM L 2?MX AS PHOSPHORESCENT DOPANTS FOR ORGANIC LEDS THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2002-10-30 EP claimed
US-20020034656-A1 Organometallic complexes as phosphorescent emitters in organic LEDs THE UNIVERSITY OF SOUTHERN CALIFORNIA 2002-03-21 US claimed
WO-2001041512-A1 COMPLEXES OF FORM L2MX AS PHOSPHORESCENT DOPANTS FOR ORGANIC LEDS THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2001-06-07 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10629827-B2 Organometallic complexes as phosphorescent emitters in organic LEDs MLX, L1CAM, POU5F1 CYP19A1 4150/4885KDM4E 3894/4885NPC1 4450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.